Healthcare provider profile · identity verified

James S Lindbom, MD

Internal Medicine · KEWANEE, IL · NPI 1740205954

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	329	87
Metoprolol Succinate	Metoprolol Succinate	319	83
Levothyroxine Sodium	Levothyroxine Sodium	299	75
Omeprazole	Omeprazole	258	69
Atorvastatin Calcium	Atorvastatin Calcium	244	70
Lisinopril	Lisinopril	232	68
Hydrochlorothiazide	Hydrochlorothiazide	200	55
Furosemide	Furosemide	189	50
Metoprolol Tartrate	Metoprolol Tartrate	179	42
Meloxicam	Meloxicam	177	44
Losartan Potassium	Losartan Potassium	176	48
Metformin Hcl	Metformin Hcl	176	50
Prednisone	Prednisone	161	73
Simvastatin	Simvastatin	155	45
Gabapentin	Gabapentin	153	37
Tamsulosin Hcl	Tamsulosin Hcl	151	46
Pantoprazole Sodium	Pantoprazole Sodium	146	37
Albuterol Sulfate Hfa	Albuterol Sulfate	142	41
Warfarin Sodium	Warfarin Sodium	136	27
Rosuvastatin Calcium	Rosuvastatin Calcium	99	28
Sertraline Hcl	Sertraline Hcl	91	26
Lorazepam	Lorazepam	89	21
Clopidogrel	Clopidogrel Bisulfate	80	25
Eliquis	Apixaban	80	18
Potassium Chloride	Potassium Chloride	80	26
Allopurinol	Allopurinol	78	24
Duloxetine Hcl	Duloxetine Hcl	78	18
Trazodone Hcl	Trazodone Hcl	77	16
Montelukast Sodium	Montelukast Sodium	76	20
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	60	21
Atenolol	Atenolol	59	14
Alendronate Sodium	Alendronate Sodium	58	14
Finasteride	Finasteride	58	15
Carvedilol	Carvedilol	57	12
Pravastatin Sodium	Pravastatin Sodium	57	18
Glipizide Er	Glipizide	56	22
Terazosin Hcl	Terazosin Hcl	53	13
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	49	32
Jardiance	Empagliflozin	47	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	47	suppressed
Azithromycin	Azithromycin	46	42
Levofloxacin	Levofloxacin	42	33
Tramadol Hcl	Tramadol Hcl	41	24
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	40	suppressed
Spironolactone	Spironolactone	40	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	38	suppressed
Cephalexin	Cephalexin	37	31
Citalopram Hbr	Citalopram Hydrobromide	36	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	35	suppressed
Fluticasone Propionate	Fluticasone Propionate	34	12
Quetiapine Fumarate	Quetiapine Fumarate	34	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	34	suppressed
Glipizide	Glipizide	33	suppressed
Xarelto	Rivaroxaban	33	11
Enalapril Maleate	Enalapril Maleate	32	suppressed
Ozempic	Semaglutide	32	suppressed
Fenofibrate	Fenofibrate	31	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	30	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	29	27
Klor-Con M20	Potassium Chloride	29	suppressed
Meclizine Hcl	Meclizine Hcl	29	11
Oxybutynin Chloride	Oxybutynin Chloride	29	suppressed
Paroxetine Hcl	Paroxetine Hcl	29	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	28	suppressed
Ezetimibe	Ezetimibe	28	suppressed
Lovastatin	Lovastatin	28	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	28	suppressed
Bupropion Xl	Bupropion Hcl	27	suppressed
Ondansetron Hcl	Ondansetron Hcl	27	20
Dutasteride	Dutasteride	26	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	26	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	25	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	25	suppressed
Buspirone Hcl	Buspirone Hcl	24	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	24	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	24	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	24	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	23	suppressed
Nifedipine Er	Nifedipine	22	suppressed
Clonazepam	Clonazepam	21	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	20	suppressed
Ibuprofen	Ibuprofen	20	suppressed
Ventolin Hfa	Albuterol Sulfate	20	suppressed
Mirtazapine	Mirtazapine	19	suppressed
Propranolol Hcl	Propranolol Hcl	19	suppressed
Celecoxib	Celecoxib	18	suppressed
Naproxen	Naproxen	18	suppressed
Solifenacin Succinate	Solifenacin Succinate	18	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	18	suppressed
Donepezil Hcl	Donepezil Hcl	17	suppressed
Ropinirole Hcl	Ropinirole Hcl	17	suppressed
Methotrexate	Methotrexate Sodium	16	suppressed
Valacyclovir	Valacyclovir Hcl	16	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	15	suppressed
Memantine Hcl	Memantine Hcl	15	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	15	suppressed
Verapamil Er	Verapamil Hcl	15	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	14	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	14	suppressed
Olanzapine	Olanzapine	14	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Estradiol (Once Weekly)	Estradiol	13	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	13	suppressed
Ondansetron Odt	Ondansetron	13	suppressed
Premarin	Estrogens, Conjugated	13	suppressed
Rybelsus	Semaglutide	13	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	12	suppressed
Baclofen	Baclofen	11	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	11	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	11	suppressed
Divalproex Sodium	Divalproex Sodium	11	suppressed
Divalproex Sodium Er	Divalproex Sodium	11	suppressed
Metronidazole	Metronidazole	11	suppressed
Nabumetone	Nabumetone	11	suppressed
Pregabalin	Pregabalin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error